KEMPHARM, INC·4

Nov 30, 7:42 PM ET

Pascoe Richard W 4

4 · KEMPHARM, INC · Filed Nov 30, 2021

Insider Transaction Report

Form 4
Period: 2021-11-30
Pascoe Richard W
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2021-11-30$7.88/sh+1,500$11,8223,285 total
Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for Richard W. Pascoe|2021-11-30

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4